ON TRACK FOR APPLICATION
TRAIN is the biomedical translation alliance in Lower Saxony, it bundles the know-how and infrastructure of university and extra-academic research for the development of active therapeutic agents. The goal is the consistent further development of new potential agents and vaccines from basic research into pre-clinical and clinical development.
Call for Proposals: Jürgen Wehland Prize for young scientists in infection research
Application deadline: 1 August, 2013
As in the previous years, the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Friends of the HZI are going to honour an excellent young researcher in the field of infection biology. The award was established in 2011 in memory of the former Scientific Director of the HZI, Professor Jürgen Wehland. The Jürgen Wehland Prize includes prize money of 5,000 Euros and will be...
The many faces of the bacterial defense system
HZI researchers discover multiple versions of microbial defense genes that lend themselves to being exploited by biotechnology
Even bacteria have a kind of “immune system” they use to defend themselves against unwanted intruders – in their case, viruses. Scientists at the Helmholtz Center for Infection Research (HZI) in Braunschweig, Germany, were now able to show that this defense system is much more diverse than previously thought and that it comes in multiple versions. Their goal is to use the various newly discovered...
Protein shaped like a spider
The immune protein C4BP is potentially suitable as a transporter for drugs.
The protein C4BP is similar to a spider in its spatial form with eight “arms”. The structure of the “spider body” has recently been described in detail by researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Technische Universität Darmstadt. This leads the scientists to unconventional ideas – the protein is possibly suitable as a scaffold for the transport of...
American biochemist to receive this year's Inhoffen Medal
HZI and TU to honour Christopher T. Walsh 25 April 2013
How do bacteria cope when exposed to toxic mercury, how are they able to outlast antibiotics, and how can they be killed using so-called "suicide inhibitors?" These are but a few of the many research topics US biochemist Christopher Walsh has devoted his career as a scientist to. On Thursday, 25 April, Walsh will be honoured for his achievements in Braunschweig, Germany: The Harvard...